Neuraxpharm Launches Change For Health Campaign To Fight Cannabis Stigma In Europe

Neuraxpharm launched its "Change for Health" campaign that aims to increase the acceptance of medical cannabis and provide better information to patients, physicians and pharmacies.

At the heart of the campaign 'Change for Health' stands a video to raise awareness, a dedicated website www.neuraxpharm.com/change-for-health which explains the campaign background and educational materials such as crosswords and myths and facts.

In Germany, the campaign is being launched on the occasion of the German Pain Congress 2022 which is held from 19.-22. October 2022 in CC Rosengarten, Mannheim. At the congress the company is present with its own booth and will furthermore sponsor the symposium "Cannabinoids in pain treatments" to raise further awareness of this high-potential treatment approach.

Neuraxpharm's campaign will be implemented at European level, starting with Germany, the Czech Republic and Switzerland, and will be extended to more countries as their legislation evolves.

Five years ago, medical cannabis was approved in Germany. Since then, demand has grown constantly. However, many doctors still seem to have reservations to prescribe medical cannabis or patients to take it, perhaps due to a lack of information. According to the platform Nowomed only one to two percent of physicians in Germany prescribe medical cannabis.

Dr. Jörg-Thomas Dierks, CEO of Neuraxpharm, stated: "Medical cannabis is still a sensitive topic surrounded by prejudices. With our campaign we want healthcare professionals, regulators, patients, and the public to rethink their perception of medical cannabis and how this treatment can help millions of patients with unmet medical needs. Because a change in our mindset towards medical cannabis will lead towards an improvement of patient's health."

Photo by Tim Foster on Unsplash

Related News

Panaxia & Neuraxpharm Launch Medical Cannabis Extracts In Europe, More Products To Come